title: Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection.
abstract: Staphylococcus epidermidis is a major pathogen in early prosthetic valve endocarditis and cerebrospinal fluid shunt infections. Approximately 10 to 15% of hospital isolates are methicillin resistant. Ten clinically significant isolates of the latter were collected for antibiotic studies in vitro and in an experimental infection in animals. Time-kill studies of five strains showed gentamicin to be the single most effective antibiotic; however, dwarf colony variants emerged as survivors with two of these strains when challenged with gentamicin alone. The addition of a second antibiotic to gentamicin did not significantly improve the bactericidal rate but prevented the emergence of variant strains. A blood culture isolate of methicillin-resistant S. epidermidis combined with 5% hog gastric mucin was used to establish an experimental intraperitoneal infection in mice. Neither methicillin nor nafcillin treatment reduced mortality below that of untreated animals. Cephalothin treatment delayed early mortality but did not diminish overall mortality. Gentamicin was the most effective single antibiotic, and gentamicin in combination with vancomycin was the most effective regimen overall. The combination of rifampin plus vancomycin was as effective as gentamicin alone. The combinations of cephalothin or nafcillin with gentamicin and cephalothin with vancomycin demonstrated antagonism. The antagonism was not due to multiple injections or drug-drug inactivation.
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D008712:Methicillin / Q000494:pharmacology; D051379:Mice; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects*; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D008712:Methicillin
references.citation: Bacteriol Rev. 1948 Jun;12(2):149-72
references.pmid: 16350119
references.citation: Proc Soc Exp Biol Med. 1963 Aug-Sep;113:1023-31
references.pmid: 14073098
references.citation: J Bacteriol. 1951 Nov;62(5):663-8
references.pmid: 14897844
references.citation: Medicine (Baltimore). 1977 Jul;56(4):287-313
references.pmid: 875718
references.citation: Antimicrob Agents Chemother. 1978 Sep;14(3):353-9
references.pmid: 708013
references.citation: J Infect Dis. 1978 Mar;137(3):245-50
references.pmid: 632623
references.citation: Antimicrob Agents Chemother. 1972 May;1(5):441-6
references.pmid: 4494488
references.citation: JAMA. 1971 Feb 22;215(8):1297-300
references.pmid: 5107559
references.citation: Antimicrob Agents Chemother (Bethesda). 1968;8:302-6
references.pmid: 5195738
references.citation: Contrib Microbiol Immunol. 1973;1:650-8
references.pmid: 4805328
references.citation: Am J Med. 1971 Jul;51(1):83-96
references.pmid: 5570321
references.citation: Am J Clin Pathol. 1966 Apr;45(4):493-6
references.pmid: 5325707
references.citation: Lancet. 1967 Jan 7;1(7480):17-9
references.pmid: 4163737
references.citation: Ann N Y Acad Sci. 1974 Jul 31;236(0):413-34
references.pmid: 4608264
references.citation: Antimicrob Agents Chemother. 1976 Mar;9(3):414-7
references.pmid: 176933
references.citation: J Infect Dis. 1972 Dec;126(6):674-8
references.pmid: 4489479
references.citation: J Lab Clin Med. 1974 Feb;83(2):241-8
references.pmid: 4810952
references.citation: Pediatrics. 1974 Jan;53(1):55-62
references.pmid: 4809195
references.citation: Circulation. 1973 Jun;47(6):1319-26
references.pmid: 4709547
references.citation: J Lab Clin Med. 1971 Sep;78(3):457-63
references.pmid: 4999161
references.citation: N Engl J Med. 1966 Jan 27;274(4):199-206 contd
references.pmid: 5323087
references.citation: Ann N Y Acad Sci. 1970 Oct 30;174(2):533-44
references.pmid: 5278134
references.citation: Ann N Y Acad Sci. 1971 Jun 11;182:258-66
references.pmid: 5285290
references.citation: Antimicrob Agents Chemother. 1976 Jun;9(6):962-9
references.pmid: 938025
references.citation: Antimicrob Agents Chemother. 1975 Sep;8(3):344-9
references.pmid: 1167043
references.citation: J Infect Dis. 1975 May;131(5):543-52
references.pmid: 1127260
references.citation: J Infect Dis. 1975 Mar;131(3):245-51
references.pmid: 1127254
references.citation: J Clin Pathol. 1968 Nov;21(6):722-8
references.pmid: 5191722
references.citation: Ann N Y Acad Sci. 1965 Jul 23;128(1):428-42
references.pmid: 5216765
references.citation: N Engl J Med. 1967 Sep 28;277(13):678-80
references.pmid: 5182623
references.citation: Surg Gynecol Obstet. 1970 Jan;130(1):94-8
references.pmid: 5410639